Understanding CARdiac Events in Breast Cancer

In Ireland, over 3,000 patients are diagnosed with breast cancer annually, and 1 in 9 Irish women will be diagnosed with breast cancer in their lifetime. There is evidence that female breast cancer survivors are more likely to die of cardiovascular disease than their age-matched counterparts. This research is focused on evaluating pathways for identifying, managing, and overcoming side effects of cancer therapies that can negatively impact quality-of-life and overall outcomes for women during and after cancer treatment. The Cardio-oncology research team at GUH plan to capitalize on their expertise in both cancer care and cardiology to develop a care pathway for cancer patients who are at increased risk of developing heart disease.

NCT Number	NCT05921279
Lead Sponsor	National University of Ireland, Galway, Ireland Collaborators: HRB Clinical Research Facility Galway, CORRIB Research Centre for Advanced Imaging and Core Lab, Galway, Ireland
Conditions	Breast Cancer, Cardiotoxicity, Cardiomyopathies, Chemotherapeutic Toxicity, Heart Failure, Oncology
Enrollment	100 participants
Start Date	2023-01-14
Primary Completion	2026-01 (estimated)
Study Completion	2026-07 (estimated)
Updated on ClinicalTrials.gov	2023-07-25